TradingView
RocketTickers
Aug 9, 2018 4:57 PM

Krystal Biotech’s KB105 Granted Orphan Drug Designation by the F Long

NASDAQ:KRYS1D
Krystal Biotech, Inc.NASDAQ

Description

⋅
KRYS: Krystal Biotech
2018-08-09 08:00:00
Krystal Biotech’s KB105 Granted Orphan Drug Designation by the FDA to Treat Patients With TGM-1 Deficient Autosomal Recessive Congenital Ichthyosis
Beyond Technical Analysis
More